UiPath's 24% Rout Was a Growth Reset, Not a Broken Business — One Number Decides the Case

On September 3, UiPath beat revenue estimates for the quarter that ended July 31 — then guided the next three months to growth of only about 8% year over year, roughly half the pace of the quarter it had just reported. The stock fell 17% the next day and about 24% across the week, giving back most of a three-month run that had carried the shares up 30% into the report.

That flush looks like panic at first glance. It wasn't arbitrary. It was a specific bet breaking, and telling the difference between a broken trade and a broken business is the whole question here.

The trade that broke

Before the earnings call, UiPath was an "agentic AI reacceleration" story. The stock had climbed 30% in three months as investors bet that automation-plus-AI would push growth back up, and the forward earnings multiple had expanded from about 15x to 21x even as the underlying business was only growing in the low teens.

Management then guided to the opposite. Third-quarter revenue is forecast at $440 million to $445 million, which works out to year-over-year growth of about 8% — a step down from 13% last quarter and 17% the quarter before that. Even with the roughly $10 million currency headwind baked into that figure, the guide describes real deceleration, not a rounding error. The company did raise its full-year revenue range modestly, to $1.789 billion to $1.794 billion, but it kept the trajectory honest: growth is no longer in double digits.

Here is where a disciplined contrarian has to stop and be careful. My usual first test — a high-growth stock whose forward multiple has compressed toward the market's, shifting the burden of proof to the bears — does not fire cleanly here. UiPath's growth has decelerated toward single digits while the multiple is also modest. That is both compressed, which is a different and less forgiving setup. The market was not wrong to reject the reacceleration narrative; the evidence did not support it.

Priced like a question, not a collapse

What the market would be wrong to conclude is that this is a broken franchise. The recurring-revenue base is holding up better than the growth-rate headline suggests. UiPath's dollar-based net retention was 109%, up two points year over year, and gross retention of 97% is best in class — customers are not leaving. Annualized recurring revenue reached $1.938 billion, up 12%. On the newest-product front, 18 of the top 20 deals in the quarter included AI components, which management says makes those deals "naturally much larger."

The more important change is that the company has quietly become a cash machine. Non-GAAP gross margin is around 82%. Operating margin came in at 22%, and the full-year guide calls for roughly $445 million of non-GAAP operating income and about $425 million of adjusted free cash flow. UiPath holds about $1.4 billion in cash and equivalents, carries no meaningful debt, and is profitable on a GAAP basis — not habitual, startup-style profitability, but real operating leverage. At a market value near $7.2 billion, the shares trade at about 3.4x trailing sales and roughly 13x guided operating income. That is not priced like a business at risk of dying; it is priced like a question about whether growth stabilizes.

The competing fear — that agentic AI is making UiPath's robotic process automation obsolete — does not match the deal evidence. The bear case at this company's foundation is "AI replaces RPA." What the quarter shows is "AI layers on top of RPA," with customers consolidating point solutions onto UiPath for the governance, orchestration, and exactness the AI layer still needs around it. That does not prove the moat is unscathed; net new ARR was a soft $37 million in the quarter, so the AI attach has not yet translated into durable expansion at scale. But "competition exists" and "moat breached" remain different claims, and the revenue-mix and retention data point to the former.

The number that decides it

The honest read is that the market earned a de-rating, and the panic may still have overshot the economics. Which one it was comes down to a single number: whether net new ARR reaccelerates from the roughly $37 million quarterly run rate through the second half. Management's own framing — "we guide to what we see in front of us," with currency headwinds baked into an already-cautious outlook — suggests the floor is conservative rather than a confession, and billings grew 24.8% in the quarter, a counter-signal to the decelerating revenue line. But guidance is a promise management chose; the ARR data is what actually happened.

The street is not screaming buy: of roughly 20 analysts covering the stock, most rate it Hold, and the mean target sits near $16, only modestly above where the shares trade after the drop. That is consistent with a stock awaiting proof rather than a story demanding rescue.

For the beginner investor the useful frame is neither "buy the dip" nor "avoid a falling knife." UiPath is a profitable, cash-generating automation leader whose growth has genuinely slowed, sold off hard because a reacceleration bet broke, and now trades at a multiple that mostly prices in the slowdown. The contrarian case here is conditional, not automatic: it only fires if the ARR number reaccelerates in the coming quarters. Until then, the selloff is a story about guidance, and the rest of the business — the margins, the cash, the 97% gross retention — still looks intact.